Pascal Pujol
Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Université de Montpellier(FR)Université Paris-Saclay(FR)CEA Valduc(FR)Cree (China)(CN)Maladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle(FR)Centre Hospitalier Universitaire de Montpellier(FR)Centre Hospitalier Universitaire de Montpellier(FR)Centre Hospitalier Régional et Universitaire de Nancy(FR)Institut de Recherche en Cancérologie de Montpellier(FR)Centre Occitanie-Montpellier(FR)Hôpital Arnaud de Villeneuve(FR)Institute of Predictive and Personalized Medicine of Cancer(ES)Institut de Recherche pour le Développement(FR)Institut de Recherche pour le Développement(FR)Laboratoire de Génétique Médicale(FR)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Nutrition, Genetics, and Disease, Estrogen and related hormone effects, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer
Most-Cited Works
- → Exemestane for Breast-Cancer Prevention in Postmenopausal Women(2011)957 cited
- → Loss of ERβ expression as a common step in estrogen-dependent tumor progression(2004)412 cited
- → Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.(1996)271 cited
- Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.(1998)
- → Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor(2008)197 cited
- → Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families(2002)188 cited
- Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.(1990)